Chemical Compound

Sograzepide

CAS Registry Number 155488-25-8
Sograzepide chemical structure
Primary Record

Sograzepide

In stock
1,934 g
Purity
98.8 %
CAS
155488-25-8

Compound Identifiers & Properties

CAS
155488-25-8
PubChem CID
9870520
SMILES
CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=N[C@H](C1=O)NC(=O)NC3=CC=CC(=C3)NC)C4=CC=CC=N4
Canonical SMILES
CNc1cccc(NC(=O)N[C@@H]2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1

Names & Synonyms

  • Sograzepide
  • netazepide
  • netazepida
  • Netazepide [INN]
  • netazepidum
  • Sograzepide [INN]
  • 155488-25-8
  • YF-476
  • YF476
  • HOU4I0G29C
  • UNII-HOU4I0G29C
  • YF 476
  • RefChem:165541
  • Gastrin inhibitor, Ferring
  • D0H7FW
  • CHEMBL324547
  • GTPL887
  • 1,9-Caryolanediol 9-acetate
  • DTXSID00165906
  • orb1706618
  • SCHEMBL1387611
  • DTXCID4088397
  • SCHEMBL29422544
  • SCHEMBL30824458
  • SCHEMBL31616255
  • YDZYKNJZCVIKPP-VWLOTQADSA-N
  • YM-476
  • C28H30N6O3
  • AMX10211
  • ZINC3810905
  • BDBM50056102
  • EX-A12362
  • MFCD00937935
  • PDSP1_000895
  • PDSP2_000881
  • AKOS027322738
  • CID9870520
  • DB12355
  • CID 6426803
  • CID:9870520
  • DA-67681
  • FD153499
  • HY-14850
  • MS-29255
  • SID:53790335
  • FE-999008
  • J806.697C
  • Cholecystokinin B Receptor Antagonist YF476
  • CS-0003594
  • NS00069253
  • N-[(3R)-1-(3,3-DIMETHYL-2-OXOBUTYL)-2,3-DIHYDRO-2-OXO-5-(2-PYRIDINYL)-1H-1,4-BENZODIAZEPIN-3-YL]-N'-[3-(METHYLAMINO)PHENYL]UREA
  • G12905
  • 937Y935
  • C104428
  • 1-((3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1h-1,4-benzodiazepin-3-yl)-3-(3-(methylamino)phenyl)urea
  • A1013134
  • Q2297773
  • 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea
  • B0084-084874
  • (R)-1-(1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-3-(3-(methylamino)phenyl)urea
  • N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea
  • 1-((3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl)-3-(3-methylaminophenyl)urea
  • 1-[(3R)-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-5-(2-pyridyl)-3H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea
  • 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea
  • 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea
  • 1-[(R)-1-(3,3-Dimethyl-2-oxo-butyl)-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-3-(3-methylamino-phenyl)-urea
  • 1-[[(3R)-1-(2-Oxo-3,3-dimethylbutyl)-2-oxo-5-(2-pyridyl)-2,3-dihydro-1H-1,4-benzodiazepin]-3alpha-yl]-3-[3-(methylamino)phenyl]urea
  • 1-[[(3R)-2,3-Dihydro-2-oxo-1-(2-oxo-3,3-dimethylbutyl)-5-(2-pyridyl)-1H-1,4-benzodiazepine]-3-yl]-3-[3-(methylamino)phenyl]urea
  • 155488-34-9
  • 3-((3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-1-(3-(methylamino)phenyl)urea
  • N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
  • R-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1 H-1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea